Skip to content
value.today

Ensoma, Inc.

🇺🇸 Boston, Massachusetts, USABiotechnologyFounded 2019
Total raised
$170 M
2 rounds on record
Latest round
$129 M
Dec 2022
First round on record
Feb 2021
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Ensoma, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2022$129 MNo. 2$50 to $250 million

Ensoma, Inc.: Raise no. 2, Dec 2022

Investors in this round

22 investors had bought by the notice of May 23, 2023: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$129 M of $129 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Emile Nuwaysir · Executive Officer, Director
  • Albert M Seymour · Director
  • Kouki M Harasaki · Director
  • Kush M Parmar · Director
  • Mark M Chin · Director
  • Nihal Sinha · Director
  • Paula Soteropoulos · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Min Wang, President. Source: SEC Form D and 1 amendment, newest notice filed May 23, 2023. Read the notice at the SEC.

equitySEC
Feb 2021$41 MNo. 1$10 to $50 million

Ensoma, Inc.: Raise no. 1, Feb 2021

Investors in this round

11 investors had bought by the notice of Feb 19, 2021: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$41 M of $71 M offered; $30 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kush Parmar · Executive Officer, Director
  • Albert Seymour · Director
  • Paula Soteropoulos · Director
  • Stephen Knight · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The Total Offering Amount and The Total Amount Sold includes the conversion of $10,549,917.81 of outstanding convertible securities.”

Signed by Kush Parmar, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 19, 2021. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Ensoma, Inc. chose not to state its revenue in its newest notice of a funding round (May 2023).

    SEC Form D · May 2023

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2023

That is all the official record says: Ensoma, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Ensoma, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 22 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Ensoma, Inc.
NameRoleNamed in
Emile NuwaysirExecutive officerMay 2023
Kush ParmarExecutive officerFeb 2021
Albert M SeymourDirectorMay 2023
Emile NuwaysirDirectorMay 2023
Kouki M HarasakiDirectorMay 2023
Kush M ParmarDirectorMay 2023
Mark M ChinDirectorMay 2023
Nihal SinhaDirectorMay 2023
Paula SoteropoulosDirectorMay 2023
Stephen KnightDirectorJan 2023
Albert SeymourDirectorFeb 2021
Kush ParmarDirectorFeb 2021